|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,768.00 JPY | -2.69% |
|
-1.95% | -2.57% |
| 06-05 | Shionogi & Co Ltd Announces New Product Launch of 'ENDEAVORRIDE' | CI |
| 06-01 | US regulator approves oral drug from Japan's Shionogi to prevent COVID-19 | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 15.1B | |||||
| 1,025B | |||||
| 559B | |||||
| 394B | |||||
| 324B | |||||
| 295B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition